Literature DB >> 19726077

Risk of combining PPIs with thienopyridines: fact or fiction?

Dirk Sibbing1, Adnan Kastrati2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726077     DOI: 10.1016/S0140-6736(09)61562-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Safety of proton pump inhibitors: current evidence for osteoporosis and interaction with antiplatelet agents.

Authors:  David A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2010-06

2.  CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: is clinical testing helpful?

Authors:  Mukesh Singh; Tejaskumar Shah; Sasikanth Adigopula; Janos Molnar; Aziz Ahmed; Sandeep Khosla; Rohit Arora
Journal:  Indian Heart J       Date:  2012-06-21

3.  How Should Patients Requiring Dual Antiplatelet Therapy be Managed When Undergoing Elective Endoscopic Gastrointestinal Procedures?

Authors:  Matthew W Sherwood; Tracy Y Wang; Richard C Becker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.